SecSonar.com

Kamada Ltd. (KMDA)

Kamada Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Kamada Ltd. (KMDA) is a Drug Manufacturers - Specialty & Generic company based in IL with a market capitalization of $451.4M. Revenue grew 12.1% year-over-year and the company generated $16.9M in free cash flow. This page tracks KMDA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 420 employees · IPO May 31, 2013

Valuation

Valuation & price

$8.00 · as of May 26, 2026 · -14.1% vs 52w high

23.1

P/E ratio

Latest-FY diluted EPS

1.68

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.20$7.91$6.62Jul 25Dec 25Jul 26Jul 7, 25$7.71Jul 9, 25$7.85Jul 11, 25$7.75Jul 15, 25$7.56Jul 17, 25$7.43Jul 21, 25$7.80Jul 23, 25$7.91Jul 25, 25$7.72Jul 29, 25$7.51Jul 31, 25$7.39Aug 4, 25$7.19Aug 6, 25$7.01Aug 11, 25$7.34Aug 13, 25$7.38Aug 15, 25$7.35Aug 19, 25$7.24Aug 21, 25$7.05Aug 25, 25$7.05Aug 27, 25$7.13Aug 29, 25$6.92Sep 3, 25$6.97Sep 5, 25$7.14Sep 9, 25$7.15Sep 11, 25$7.02Sep 16, 25$7.03Sep 18, 25$6.96Sep 22, 25$6.99Sep 24, 25$6.89Sep 26, 25$6.67Sep 30, 25$6.94Oct 2, 25$6.80Oct 6, 25$6.70Oct 8, 25$6.84Oct 10, 25$6.80Oct 14, 25$6.82Oct 16, 25$6.75Oct 21, 25$6.93Oct 23, 25$6.85Oct 27, 25$7.03Oct 29, 25$6.92Oct 31, 25$6.92Nov 4, 25$6.67Nov 6, 25$6.62Nov 10, 25$7.02Nov 12, 25$7.28Nov 14, 25$6.99Nov 18, 25$6.84Nov 20, 25$6.68Nov 25, 25$6.80Nov 28, 25$6.70Dec 2, 25$6.92Dec 4, 25$7.11Dec 8, 25$6.73Dec 10, 25$7.03Dec 12, 25$7.02Dec 16, 25$7.12Dec 18, 25$7.22Dec 22, 25$7.07Dec 24, 25$7.09Dec 29, 25$7.05Jan 2, 26$7.03Jan 6, 26$7.43Jan 8, 26$7.95Jan 12, 26$8.06Jan 14, 26$7.96Jan 16, 26$8.17Jan 21, 26$7.79Jan 23, 26$7.92Jan 27, 26$8.87Jan 29, 26$8.37Feb 2, 26$8.24Feb 4, 26$8.10Feb 9, 26$8.28Feb 11, 26$8.51Feb 13, 26$8.50Feb 18, 26$8.85Feb 20, 26$8.80Feb 24, 26$9.20Feb 26, 26$8.91Mar 2, 26$9.07Mar 4, 26$9.19Mar 6, 26$8.86Mar 10, 26$8.96Mar 12, 26$8.69Mar 17, 26$8.89Mar 19, 26$8.62Mar 23, 26$8.20Mar 25, 26$8.20Mar 27, 26$8.15Mar 31, 26$8.34Apr 2, 26$8.47Apr 7, 26$8.25Apr 9, 26$8.51Apr 13, 26$8.44Apr 15, 26$8.44Apr 17, 26$8.49Apr 22, 26$8.36Apr 24, 26$8.28Apr 28, 26$8.15Apr 30, 26$8.14May 4, 26$8.29May 6, 26$8.28May 8, 26$8.55May 12, 26$8.43May 14, 26$8.03May 18, 26$7.83May 20, 26$7.87May 22, 26$7.83May 28, 26$7.86Jun 1, 26$7.70Jun 3, 26$7.39Jun 5, 26$7.17Jun 9, 26$7.24Jun 11, 26$7.44Jun 15, 26$7.46Jun 17, 26$7.26Jun 22, 26$7.19Jun 24, 26$7.14Jun 26, 26$7.26Jul 2, 26$7.50
$6.6052-week range$9.31
Loading valuation history…

Fundamentals

Key fundamentals

$451.4M

Market cap

12.1%

Revenue growth (YoY)

42.3%

Gross margin

$16.9M

Free cash flow (USD)

-$63.9M

Net debt

Net cash position

0.3%

Share dilution

2/6

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$77.5MFY 2017$102.8MFY 2018$114.5MFY 2019$127.2MFY 2020$133.2MFY 2021$103.6MFY 2022$129.3MFY 2023$142.5MFY 2024$161.0MFY 2025$180.5M
$77.5M$180.5M

Free cash flow by year

2016 → 2025

FY 2016$-744.0KFY 2017$-559.0KFY 2018$7.7MFY 2019$26.1MFY 2020$13.6MFY 2021$-13.0MFY 2022$24.8MFY 2023$-1.5MFY 2024$36.9MFY 2025$16.9M
-$744K$16.9M

Gross margin by year

2021 → 2025

FY 202129.3%FY 202236.1%FY 202338.9%FY 202443.5%FY 202542.3%
29.3%42.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingAnnual General Meeting NoticeJun 18, 2026Filing
  • 6-K filingFDA Approval AnnouncementJun 1, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 13, 2026Filing
  • Annual reportAnnual Report FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Kamada Ltd.'s market cap?

Kamada Ltd. (KMDA) has a market capitalization of $451.4M.

What is KMDA's P/E ratio?

KMDA trades at a price-to-earnings ratio of 23.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is KMDA's price-to-book (P/B) ratio?

KMDA trades at 1.68 times book value per share.

Are insiders buying KMDA stock?

SEC Form 4 filings show no open-market insider buys at Kamada Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

CGC

Canopy Growth Corporation

$468.3M

EOLS

Evolus, Inc.

$434.3M

AQST

Aquestive Therapeutics, Inc.

$404.7M

SNDL

SNDL Inc.

$383.8M

SIGA

SIGA Technologies, Inc.

$340.3M

ORGO

Organogenesis Holdings Inc.

$331.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.